Literature DB >> 3296994

Cell invasiveness of Proteus mirabilis and Proteus vulgaris strains.

A Rózalski, H Długońska, K Kotełko.   

Abstract

Cell penetration ability of haemolytic and non haemolytic Proteus rods was compared. Among four Proteus strains all were able to invade the tested cells (Vero 135, HeLa, L-929 and human blood lymphocytes) but the expression of this feature by haemolytic strains was markedly higher. The survival and multiplication of intracellular bacteria, especially in the case of fresh human blood lymphocytes may be of importance for the development of infection in higher organisms.

Entities:  

Mesh:

Year:  1986        PMID: 3296994

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  6 in total

Review 1.  Proteus spp. as Putative Gastrointestinal Pathogens.

Authors:  Amy L Hamilton; Michael A Kamm; Siew C Ng; Mark Morrison
Journal:  Clin Microbiol Rev       Date:  2018-06-13       Impact factor: 26.132

Review 2.  Potential virulence factors of Proteus bacilli.

Authors:  A Rózalski; Z Sidorczyk; K Kotełko
Journal:  Microbiol Mol Biol Rev       Date:  1997-03       Impact factor: 11.056

3.  Characterization of cell-bound and cell-free hemolytic activity of Proteus strains.

Authors:  W Kaca; A Rózalski
Journal:  Eur J Epidemiol       Date:  1991-03       Impact factor: 8.082

Review 4.  Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis.

Authors:  S M Jacobsen; D J Stickler; H L T Mobley; M E Shirtliff
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

5.  Hemolytic activity and invasiveness in strains of Proteus penneri.

Authors:  A Rozalski; K Kotełko
Journal:  J Clin Microbiol       Date:  1987-06       Impact factor: 5.948

6.  Professor Krystyna Kotełko and her contribution to the study of Proteus endotoxin.

Authors:  Antoni W Różalski
Journal:  Innate Immun       Date:  2018-04       Impact factor: 2.680

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.